Benlysta does not work as quickly as the Cellcept/voclosporin combo, so it's generally not recommended as induction therapy.
1 day ago
Great question! Belimumab (Benlysta) has shown promising results when added to standard induction therapy for lupus nephritis. Here's a summary of key research findings:
Belimumab works by blocking a protein called BLyS (B-lymphocyte stimulator), which helps harmful B cells survive. In lupus nephritis, these B cells produce Show Full Answer
Great question! Belimumab (Benlysta) has shown promising results when added to standard induction therapy for lupus nephritis. Here's a summary of key research findings:
Belimumab works by blocking a protein called BLyS (B-lymphocyte stimulator), which helps harmful B cells survive. In lupus nephritis, these B cells produce autoantibodies that attack kidney tissue. By targeting the source of inflammation directly, belimumab adds a layer of protection that standard therapies alone may not provide. When used alongside standard induction therapy at higher doses over time, belimumab has been shown to:
- Reduce levels of harmful autoantibodies
- Improve kidney lab results and lupus nephritis stability
- Lower the risk of severe lupus flares
- Reduce the amount of steroids needed to manage lupus
It's worth noting that full benefits can take several months to appear, so patience is key. There are some important risks to be aware of when adding belimumab to a treatment plan:
- Serious infections
- Severe allergic reactions (rare)
- Depression and suicidal thoughts
- Injection site reactions
- Fatigue and headaches
Always discuss these risks thoroughly with a rheumatologist or nephrologist before making any changes to a treatment plan.
2 days ago
Hi, this is just a check-in, based on a phrase you mentioned. If you — or anyone else who sees this — is thinking about self-harm, we want to say that you are an important part of this community. No part of this is easy, but there is support that can help.
Read more >
Join
Your Privacy Choices
